Duova 18 Mcg/9 Mcg Inhaler (1), a prescription drug, is manufactured in various forms such as Inhaler. Secondary and off-label uses of Duova 18 Mcg/9 Mcg Inhaler (1) have also been mentioned below.
The right dosage of Duova 18 Mcg/9 Mcg Inhaler (1) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Duova 18 Mcg/9 Mcg Inhaler (1) side effects, there are can be others also. These have been listed below. Usually, these side effects of Duova 18 Mcg/9 Mcg Inhaler (1) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Duova 18 Mcg/9 Mcg Inhaler (1)'s effect during pregnancy is Severe and Severe while nursing. Warnings related to Duova 18 Mcg/9 Mcg Inhaler (1)'s effects on the liver, heart and kidney, if any, have been listed below.
Duova 18 Mcg/9 Mcg Inhaler (1) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema are examples of such conditions. Other contraindications of Duova 18 Mcg/9 Mcg Inhaler (1) have been discussed in the sections ahead.
Additionally, Duova 18 Mcg/9 Mcg Inhaler (1) may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Duova 18 Mcg/9 Mcg Inhaler (1) is safe while driving, and is is addictive in nature.
Duova 18 Mcg/9 Mcg Inhaler (1) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Duova 18 Mcg/9 Mcg Inhaler (1) is used -
Severe
Moderate
Mild
Is the use of Duova 18 Mcg/9 Mcg Inhaler (1) safe for pregnant women?
Duova can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Duova 18 Mcg/9 Mcg Inhaler (1) safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Duova. So it is adviced to consult the doctor before using it.
What is the effect of Duova 18 Mcg/9 Mcg Inhaler (1) on the Kidneys?
Duova rarely harms the kidneys.
What is the effect of Duova 18 Mcg/9 Mcg Inhaler (1) on the Liver?
There may be an adverse effect on the liver after taking Duova. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Duova 18 Mcg/9 Mcg Inhaler (1) on the Heart?
The heart can be affected by Duova. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Duova 18 Mcg/9 Mcg Inhaler (1) unless your doctor advises you to do so -
Is this Duova 18 Mcg/9 Mcg Inhaler (1) habit forming or addictive?
No, there is no any evidence that Duova 18 Mcg/9 Mcg Inhaler (1) is addictive.
Interaction between Food and Duova 18 Mcg/9 Mcg Inhaler (1)
Due to the absence of research, it is difficult to say how Duova 18 Mcg/9 Mcg Inhaler (1) and food will interact.
Interaction between Alcohol and Duova 18 Mcg/9 Mcg Inhaler (1)
Taking alcohol with Duova 18 Mcg/9 Mcg Inhaler (1) can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1207
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Spiriva® HandiHaler® (tiotropium bromide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Braltus® (tiotropium bromide)
